GRAL: GRAIL, Inc.
Performance
GRAL +61.31%
Watchlist
Select an item
Summary
GRAL at a glance
GRAL returned +61.31% over the past year. Its worst drop in that year was -62.92%, smaller than 11% of stocks on Redstone, and its Sharpe ratio of 1.01 beats 76% of stocks on Redstone. It pays no dividends.
Current Drawdown
-19.41%
Rolling Volatility
103.30%
Actions
Metrics
Risk Indicators
Alpha74.18%
Beta2.95x
Sharpe1.01
Sortino1.41
Omega1.22
Calmar0.97
Martin2.82
Profile
About GRAL
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $5.7B
- Listed
- Jun 2024
- Employees
- 910
- Headquarters
- Menlo Park, CA
- Website
- grail.com
Comparisons